Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

Agreed, I would think they would have to announce a decision to shut down AXAL within the three day required window (or whatever it is for disclosing a material event). I can't think of many events that are more "material" than shutting down a trial we've pumped tens of millions into already whose closure essentially changes Advaxis overnight from being a late stage Phase 3 company to an early stage company.

I remain hopeful a deal is in the works. If it weren't, Berlin likely would have made the shutdown announcement at the time of the earnings release. The current corporate presentation dated shortly before the earnings announces says the company is actively seeking a partnership on AXAL.

Get it done Berlin and let's get back to the minimum fair value for most Phase 3 companies (around $300 million +).